| Literature DB >> 34262476 |
Mikhail Santos Cerqueira1, Eduardo Caldas Costa2, Ricardo Santos Oliveira2, Rafael Pereira3, Wouber Hérickson Brito Vieira1.
Abstract
Blood flow restriction (BFR) training combines exercise and partial reduction of muscular blood flow using a pressured cuff. BFR training has been used to increase strength and muscle mass in healthy and clinical populations. A major methodological concern of BFR training is blood flow restriction pressure (BFRP) delivered during an exercise bout. Although some studies increase BFRP throughout a training intervention, it is unclear whether BFRP adjustments are pivotal to maintain an adequate BFR during a training period. While neuromuscular adaptations induced by BFR are widely studied, cardiovascular changes throughout training intervention with BFR and their possible relationship with BFRP are less understood. This study aimed to discuss the need for BFRP adjustment based on cardiovascular outcomes and provide directions for future researches. We conducted a literature review and analyzed 29 studies investigating cardiovascular adaptations following BFR training. Participants in the studies were healthy, middle-aged adults, older adults and clinical patients. Cuff pressure, when adjusted, was increased during the training period. However, cardiovascular outcomes did not provide a plausible rationale for cuff pressure increase. In contrast, avoiding increments in cuff pressure may minimize discomfort, pain and risks associated with BFR interventions, particularly in clinical populations. Given that cardiovascular adaptations induced by BFR training are conflicting, it is challenging to indicate whether increases or decreases in BFRP are needed. Based on the available evidence, we suggest that future studies investigate if maintaining or decreasing cuff pressure makes BFR training safer and/or more comfortable with similar physiological adaptation.Entities:
Keywords: discomfort; kaatsu training; pain; perceived; resistance training; vascular occlusion exercise
Year: 2021 PMID: 34262476 PMCID: PMC8273389 DOI: 10.3389/fphys.2021.678407
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Cardiovascular outcomes and their potential impacts on blood flow restriction pressure.
| Outcomes | Definition | Measurement | Possible physiological repercussion | Possible repercussions on BFRP |
| FMD | Measurement of endothelial function. Defined as the artery dilatation in response to increases in blood flow | Doppler ultrasonography | Lower FMD indicates a reduction in endothelial function; increased FMD reflects an increase in reactive hyperemia | Lower FMD may be related to reduced vasodilatory response and increased BP and BFRP |
| Arterial compliance | The ability of an artery to expand and recoil during cardiac contraction and relaxation | PWV; CAVI; Doppler ultrasound | Its reduction is associated with increased BP; its increase is associated with reduced BP | Its reduction may result in increased BFRP; its increase may result in reduced BFRP |
| Arterial Stiffness | The decrease in arterial distensibility | PWV; CAVI | Its reduction may result in a reduced SBP; its increase may increase BP | Its reduction may result in a reduction of BFRP; its increase may result in increased BFRP |
| Arterial diameter | The straight line passing from side to side through the center of an artery | Doppler ultrasonography | Its reduction may result in increased SBP; its increase may result in a BP reduction. | Its reduction may result in increased BFRP; its increase may result in a reduced BFRP |
| Capillarity Index (microvascular filtration capacity) | An indirect measurement of the amount (expansion) of the capillary network | Plethysmography | Its reduction may result in increased peripheral vascular resistance and SBP; its increase may result in reduced peripheral vascular resistance and BP | Its reduction can result in increased BFRP; its increase may result in reduced BFRP |
| Blood pressure | The pressure of the blood against the inner walls of the blood vessels | Sphygmomanometer; Oscillometric device | It may be influenced by cardiac output, total peripheral resistance, and arterial stiffness. | Its reduction may result in reduced BFRP; its increase may result in increased BFRP |
| Heart rate | The number of times that the heart beats per minute | Electrocardiogram; Heart rate monitor | Its reduction may result in reduced BP; its increase may result in increased BP | Its reduction may result in reduced BFRP; its increase may result in increased BFRP |
| Heart rate variability | The variability of successive heart rate intervals | Heart rate monitor | Activation of baroreceptors leads to greater parasympathetic activity and sympathetic withdrawal | Increased parasympathetic activity and sympathetic withdrawal lead to hemodynamic adjusts, and increases in BFRP may be necessary |
Characteristics of the studies that investigated the effects of BFR training on cardiovascular outcomes.
| Reference (year) | Sample (n) | Exercises protocol | Cardiovascular outcomes | BFR protocol | BFRP adjusted yes/no (reason) | Main findings |
| Young males (30) | Leg press, knee flexion, and knee extension (20% 1RM; 2 sets of 10 reps; 3x/week; 3 weeks) | AC, HR, SBP, and DBP | BFRP: 20% above systolic SBP; Cuff width: 5 cm | No (NR) | ↔ | |
| Young males and females (20) | Handgrip (60% MVC; 15 grips/min; 20 min; 3x/week; 4 weeks) | FMD and AD | BFRP:80 mmHg; Cuff width: 4 cm | No (NR) | ↓FMD and ↔ for other outcomes | |
| Young males (9) | Heel raises (30% MVC; 4 sets of 50 reps; 3x/week; 4 weeks) | MFC | BFRP:150 mmHg; Cuff width: 15 cm | No (NR) | ↑MFC | |
| Young females (16) | Heel raises (25–50% 1RM; 3 sets until failure; 3x/week; 4 weeks) | RH | BFRP:110 mmHg; Cuff width: NR | No (NR) | ↑RH | |
| Young males and females (16) | Knee extension (30% 1RM; 3 sets until failure; 3x/week; 4 weeks) | PWV | BFRP:30% above SBP; Cuff width: 6 cm | No (NR) | ↔ | |
| Young males (10) | Knee extension (15% MVC; reps until failure; 4x/week; 4 weeks) | HR, SBP, and DBP | BFRP:230 mmHg; Cuff width: 13 cm | No (NR) | ↑DBP and ↔ for other outcomes | |
| Young males (9) | Handgrip (40% 1RM; 3 sets until failure; 3x/week; 4 weeks) | FMD and AD | BFRP:80 mmHg; Cuff width:13 cm | No (NR) | ↑AD and ↔ for other outcomes | |
| Young males (46) | Knee extension and knee flexion exercises (20% 1RM; 75 reps; 3x/week; 6 weeks) | AC, HR, SBP, DBP, and VCo | BFRP:160–200 mmHg; Cuff width: 5 cm | Yes (NR) | ↑VCo ↓DBP and ↔ for other outcomes | |
| Young males (19) | Bench press (30% 1RM; 30 reps; 3x/week; 6 weeks) | AC, SBP, and DBP | BFRP:100–160 mmHg; Cuff width: 3 cm | Yes (to reduce arterial blood flow by 60% at rest and by 30% during exercise) | ↔ | |
| Young males (11) | Heel raises (30% of 1RM; 3 sets until failure; 3x/week; 6 weeks) | FMD and AD | BFRP:110 mmHg; Cuff width: 13 cm | No (NR) | ↑FMD ↑AD | |
| Young males and females (16) | Knee extension (30% 1RM; 2–4 sets until failure;3x/week; 6 weeks) | PWV | BFRP: 80% of total restriction pressure; Cuff width: 5 cm | No (NR) | ↑PWV | |
| Young males (17) | Handgrip (30% MVC; 30 reps per minute for 3 min; 3x/week; 4 weeks) | HR and MAP | BFRP:75–150% of SBP; Cuff width: NR | Yes (NR) | ↓MAP and ↔ for other outcomes | |
| Young males and females (40) | Biceps curl and knee extension (15% 1RM; 4 sets of 90 reps; 2x/week; 8 weeks) | VCo | BFRP: 40 and 80% of total restriction pressure Cuff width: 5 cm | No (NR) | ↑VCo | |
| Young males (10) | Interval cycling (61–81% of MAPO; 3 sets of three 2-min bouts; 3x/week; 6 weeks) | AD | BFRP: 180 mmHg; Cuff width: 13 cm | No (NR) | ↑AD | |
| Young males and females (31) | Biceps curl, elbow extension, knee extension, leg curl and heel raise (30% 1RM; 3sets of 30 reps; 2–3x/week; 8 weeks | HR, SBP, DBP, and FMD | BFRP: 250 or 350 mmHg Cuff width: 5.5 or 7.0 cm | No (NR) | ↓SBP ↑FMD and ↔ for other outcomes | |
| Young males (28) | Elbow flexion and knee extension (30% 1RM; 4 sets of 21–23 reps; 3x/week; 8 weeks) | FMD | BFRP: 20 mmHg below SBP; Cuff width: 14–16 cm | No (NR) | ↑FMD | |
| Young males (24) | Elbow flexion (30% 1RM; 5 sets of 20 reps; 5xweek; 8 weeks) | HR, SBP, DBP, and MAP | BFRP: 65 or 130% of SBP; Cuff width: NR | No (NR) | ↓HR and ↔ for other outcomes | |
| Older males and females (23) | Treadmill walking (45% of heart rate reserve; 20 min; 4x/week; 10 weeks) | AC, HR, SBP, and DBP | BFRP:140–200 mmHg; Cuff width: 5 cm | Yes (to impose progressive overload in muscle and central circulation) | ↑AC and ↔ for other outcomes | |
| Older males and females (10) | Heel raises (25% 1RM; 3 sets until failure;3x/week; 4 weeks) | RH | BFRP:110 mmHg; Cuff width: NR | No (NR) | ↑RH | |
| Older males and females (19) | Knee extension and leg press (20–30% 1RM; 75 reps; 2x/week; 12 weeks) | FMD, HR, SBP, DBP, and AS | BFRP:120–270 mmHg; Cuff width: 5 cm | Yes (to achieve high levels of perceived effort). | ↑FMD and ↔ for other outcomes | |
| Older females (14) | Arm curl and triceps down (elastic resistance; 75 reps; 2x/week; 12 weeks) | HR, SBP, DBP, FMD, and AS | BFRP:120–270 mmHg; Cuff width: 3 cm | Yes (to achieve high levels of perceived effort). | ↔ | |
| Older males and females (17) | Arm curl and triceps down (Elastic resistance; 75 reps; 2x/week; 12 weeks) | HR, SBP, DBP, FMD, and AS | BFRP:120–270 mmHg; Cuff width: 3 cm | Yes (to achieve high levels of perceived effort). | ↔ | |
| Older males and females (40) | Leg extension, leg press, rowing and chest press (20% 1RM; 3 × 20 reps; 3x/week; 4 weeks) | RH | BFRP: 100% of SBP Cuff width: 10 or 7 cm | No (NR) | ↑RH | |
| Young and older males and females (27) | Handgrip (20% MVC; 3 sets until failure; 2x/week; 4 weeks) | VCo, HR, SBP, and DBP | BFRP:130% of SBP; Cuff width: 16 cm | No (NR) | ↑VCo and ↔ for other outcomes | |
| Middle-aged males (21) | Treadmill walking (6 km⋅h–1, 5% grade; 5 sets of 3 min; 3x/week; 6 weeks) | HR and HRV | BFRP:80–100 mmHg; Cuff width: 18 cm | Yes (to allow participants to adapt to the BFRP during the early phase of the training) | ↓HR ↑HRV | |
| Middle-aged males (21) | Treadmill walking (6 km⋅h–1, 5% grade; 5 sets of 3 min; 3x/week; 6 weeks) | SBP, DBP, and HRV | BFRP:80–100 mmHg; Cuff width: 18 cm | Yes (to allow participants to adapt to the BFRP during the early phase of the training) | ↑HRV ↓SBP and ↔ for other outcomes | |
| Hypertensive females (23) | Wrist flexion (30% MVC; 3 sets until failure; 2x/week; 8 weeks) | HR, SBP, and DBP | BFRP:70% of SBP; Cuff width: NR | Yes; based on SBP (to adjust BFRP to SBP in each training session). | ↓SBP ↓DBP and ↔ for other outcomes | |
| Patients with chronic kidney disease | Handgrip (40% MVC; 3 sets of 20 reps; 2x/week; 8 weeks) | AD | BFRP:50% of SBP; Cuff width: NR | No (NR) | ↑AD | |
| Patients with coronary artery disease (24) | Knee extensions (30–40% 1RM; 3 sets of 8–12 reps; 2x/week; 8 weeks) | HR, SBP, and DBP | BFRP:15–20 mmHg above systolic BP; Cuff width: 23 cm | Yes (NR) | ↓SBP and ↔ for other outcomes | |
Methodological quality of eligible studies (n = 29).
| Study | PEDro scale itemsa | PEDro score | ||||||||||
| 1b | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | (0–10) | |
| Y | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7 | |
| Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 | |
| Y | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| N | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| N | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7 | |
| N | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| N | N | N | Y | N | N | Y | Y | Y | Y | Y | 6 | |
| N | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| N | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 | |
| N | Y | N | Y | N | N | Y | Y | Y | Y | Y | 6 | |
| N | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7 | |
| N | Y | N | Y | N | N | N | Y | N | Y | Y | 5 | |
| Y | Y | N | Y | N | N | N | N | Y | Y | Y | 6 | |
| N | N | N | Y | N | N | N | Y | Y | Y | Y | 5 | |
| N | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 | |
| Y | Y | Y | Y | N | N | N | Y | N | Y | Y | 6 | |
| Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 | |
| Y | Y | N | Y | N | N | N | N | N | Y | Y | 4 | |
| Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 6 | |
| N | Y | N | Y | N | N | N | N | N | Y | Y | 4 | |
| N | Y | N | Y | N | N | N | Y | N | Y | Y | 5 | |
| N | Y | N | Y | N | N | N | Y | N | Y | Y | 5 | |
| Y | Y | Y | N | N | N | N | Y | Y | Y | Y | 6 | |
| N | Y | N | Y | N | N | N | Y | N | Y | Y | 5 | |
| N | Y | N | Y | N | N | Y | N | N | Y | Y | 5 | |
| N | Y | N | Y | N | N | N | Y | N | Y | Y | 5 | |
| Y | Y | N | Y | N | N | Y | Y | N | Y | Y | 6 | |
| N | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 | |